- Report
- April 2024
- 309 Pages
Global
From €4277EUR$4,499USD£3,593GBP
- Report
- April 2024
- 339 Pages
Global
From €6797EUR$7,150USD£5,710GBP
- Report
- October 2024
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- August 2024
- 150 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 302 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- August 2024
- 62 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- May 2024
- 140 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- December 2024
- 150 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- April 2024
- 80 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2024
- 100 Pages
Africa
From €1901EUR$2,000USD£1,597GBP
- Report
- October 2024
- 70 Pages
Latin America
From €903EUR$950USD£759GBP
- Report
- September 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 114 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- November 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP

Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more